Dr. Gerstner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8940 N Wood Sage Rd
Peoria, IL 61615Phone+1 309-243-3000Fax+1 309-243-3215
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2005 - 2008
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2002 - 2005
- Southern Illinois University School of MedicineClass of 2002
Certifications & Licensure
- IL State Medical License 2008 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Daratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma Start of enrollment: 2020 Aug 07
Publications & Presentations
PubMed
- 2 citationsFive-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A ext...Martin Reck, Rafal Dziadziuszko, Shunichi Sugawara, Steven Kao, Maximilian Hochmair
Lung Cancer. 2024-10-01 - 3 citationsPhase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack
Clinical Cancer Research. 2023-09-15 - 84 citationsEffect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Random...Thomas E. Stinchcombe, Pasi A. Jänne, Xiaofei Wang, Erin M. Bertino, Jared Weiss
JAMA Oncology. 2019-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: